Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1997 1
2000 1
2006 1
2007 2
2008 6
2009 5
2010 12
2011 20
2012 31
2013 38
2014 47
2015 25
2016 31
2017 41
2018 66
2019 71
2020 59
2021 51
2022 3
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 29074818

424 results
Results by year
Filters applied: . Clear all
Page 1
Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.
Liabeuf S, Ryckelynck JP, El Esper N, Ureña P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Prié D, Choukroun G; FRENCH Study collaborators. Liabeuf S, et al. Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1930-1940. doi: 10.2215/CJN.03030317. Epub 2017 Oct 26. Clin J Am Soc Nephrol. 2017. PMID: 29074818 Free PMC article. Clinical Trial.
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.
Ruggiero B, Trillini M, Tartaglione L, Rotondi S, Perticucci E, Tripepi R, Aparicio C, Lecchi V, Perna A, Peraro F, Villa D, Ferrari S, Cannata A, Mazzaferro S, Mallamaci F, Zoccali C, Bellasi A, Cozzolino M, Remuzzi G, Ruggenenti P, Kohan DE; ANSWER Study Organization. Ruggiero B, et al. Am J Kidney Dis. 2019 Sep;74(3):338-350. doi: 10.1053/j.ajkd.2019.01.029. Epub 2019 Apr 23. Am J Kidney Dis. 2019. PMID: 31027883 Clinical Trial.
Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial.
Ureña-Torres P, Prié D, Keddad K, Preston P, Wilde P, Wan H, Copley JB. Ureña-Torres P, et al. BMC Nephrol. 2014 May 5;15:71. doi: 10.1186/1471-2369-15-71. BMC Nephrol. 2014. PMID: 24885942 Free PMC article. Clinical Trial.
The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y, Cluet Y, Titeca-Beauport D, El Esper N, Ureña P, Bodeau S, Combe C, Dussol B, Fouque D, Choukroun G, Liabeuf S. Bennis Y, et al. Toxins (Basel). 2019 May 17;11(5):279. doi: 10.3390/toxins11050279. Toxins (Basel). 2019. PMID: 31109001 Free PMC article. Clinical Trial.
Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study.
Chen N, Wu X, Ding X, Mei C, Fu P, Jiang G, Li X, Chen J, Liu B, La Y, Hou F, Ni Z, Fu J, Xing C, Yu X, Huang C, Zuo L, Wang L, Hunter J, Dillon M, Plone M, Neylan J. Chen N, et al. Nephrol Dial Transplant. 2014 Jan;29(1):152-60. doi: 10.1093/ndt/gft232. Epub 2013 Oct 22. Nephrol Dial Transplant. 2014. PMID: 24151017 Clinical Trial.
424 results